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Abstract. We describe the representation of the chemical affinity be-
tween the antigen-combining site of the immunoglobulin molecule and
the antigen molecule as the probability of the two molecules existing in a
bound state. Our model is based on the identification of shape attractors
in the configuration space for the joint antibody / antigen combining site
sequence. We parameterize configuration space in terms of Ramachan-
dran angles. The shape attractors allow us to construct a Markov chain
whose steady state distribution gives rise to the desired attachment prob-
ability. As a result we are able to delineate the enthalpic, entropic and
kinetic components of affinity and study their interactions.
1 Overview
Structural and thermodynamic details underlying antibody-antigen interaction
reveal that the correlation between mutations, free energy improvements and
increase in affinity are more complex and subtle and cannot be completely cap-
tured through local interactions. Mutations in non-binding residues may underlie
increases in affinity due to long-range effects such as stabilization of charge dis-
tributions, decreasing conformational strain, or perhaps creating a permissive
environment for further affinity improving mutations by altering accessible re-
gions of the shape space being explored. Recent literature on the evolution of
affinity at the protein-protein interface has attempted to elucidate the more com-
plex nature of cooperative effects as well as the ability of diverse na¨ive antibodies
to exploit different thermodynamic pathways in order to bind a given antigenic
epitope [12, 10]. It is natural to extend these pathway explorations to the process
of affinity maturation.
Our goal is to decompose this search for higher affinity using a hierarchical
model that attempts to capture the dynamics at the level of the protein-protein
interaction. Individual immunoglobulin (Ig) genotypes, together with locally ex-
pressed antigenic epitopes, are mapped to a set of ‘shape attractors’. These
attractors in turn generate a Markov chain, which models the thermodynamic
relaxation of the ‘binding pocket’. An ‘affinity landscape’ is constructed, by al-
lowing the shape attractors to perform a coalescing random walk as a result of
the hypermutation process. Evolving immunologic affinity is the resulting path
2 Patricia Theodosopoulos et al.
of the steady state probability of the bound state. Convergence analysis of this
process decomposes affinity maturation into its enthalpic, kinetic and entropic
components.
This paradigm seeks to capture the statistical mechanics of antigen-antibody
interaction, rather than details of the mutational process. Emergence of alter-
nate optimization pathways may facilitate understanding of evolved strategies
of affinity maturation and why some optimization paths may be better suited to
some types of antigens than others.
2 Background
Primary antibody diversity is sufficient to bind the vast majority of antigens
[6, 14]. As a result of stimulation of the system by protein antigen, somatic hy-
permutation and/or gene conversion, followed by selection occurs in order to
generate antibodies which have a higher affinity for a particular antigen and
can rapidly and effectively respond as immediate effectors as well as generating
immunologic memory [6]. Structurally, this is typically understood as the pro-
gression from an ‘induced fit’ for the antigen to a ‘lock and key’ with enhanced
pre-binding shape complementarity [10, 23, 13].
The nature of the protein-protein interaction that occurs upon binding is dic-
tated by biophysical parameters which include electrostatics, hydrogen bonds,
hydrophobic packing, van der Waals interactions as well as shape and charge
complementarity and cooperative binding effects. The degree of these effects
depends upon the chemical composition of the residues of the interacting com-
ponents [12, 11]. Mutational analyses have shown the selection of clones that
undergo a stepwise increase in affinity – an additive effect of changes that cre-
ate new hydrogen bonds, electrostatic or hydrophobic interactions between the
residues of the antigen epitope, the antibody variable region, and associated sol-
vent molecules [17, 23]. However, it is observed that some codon changes cannot
be translated into stepwise energetic changes [17] and therefore prediction of
affinity effects by a given mutation are often not directly quantifiable. Affinity
maturation studies of multiple systems fail to reveal a consistent optimization
strategy [23, 9, 15, 19, 24]. Some mutations may create residues which are involved
in long range or cooperative binding, while other mutations may be neutral from
an affinity perspective, but may actually be permissive of subsequent affinity en-
hancing mutations [17, 7, 20].
3 Model Description
The antigen-combining site of the antibody molecule consists of six hypervariable
loop structures which extend from the barrel-shaped pairing of the beta strands
of the variable regions of the heavy and light chains. The lengths and chemical
compositions of these loops determine their binding capabilities [27]. Canonical
structures have been identified for the hypervariable loops, including the third
hypervariable region of the heavy chain (CDRH3) which typically has the most
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contact residues with the antigen, and is also the most variable in length and
sequence [4, 5].
The hypermutation process acts primarily on the CDR coding sequences, and
there is ample evidence for mutation ‘hotspots’ and coding bias in the variable
(V) genes [18, 16]. Certain V genes may have evolved to be more mutable, and
others more robust [7, 16]. It is likely that the mutational process takes advantage
of biases in the V gene sequences and that subsequent mutations would attempt
to create flexibility in some regions to facilitate docking while other regions are
optimized to maximize antigen-antibody interactions and stabilize binding for
appropriate feedback and signaling to occur [7, 24, 26].
We define three regions of each CDR loop; region 1 representing the anchored
ends of the loop, region 2 is the segment extending to the base of the turn of the
loop and region 3 representing the residues of the turn. The amino acids (see
[27] for the one-letter amino acid codes) are classified in five groupings which
reflect some of the properties of other amino acid classification systems [2], yet
our groupings are based on chemical properties that emphasize their positional
effects on entropy, enthalpy and kinetics of binding and thus the relative contri-
butions to the strength of the attractors in the model system.
I Aliphatics- V, L, I, M
II Aromatics- Y, W, F, H
III Mobile aliphatic- A, G
IV Polar/charged, mobile- S, T, Q, C, N, E, D
V Basic, low mobility- K, R, P
Group I represent most of the aliphatic amino acids. These are not ideal in the
combining site due to limited interaction potential, but participate hydrophobi-
cally in stabilizing and stacking interactions. Their rotational degrees of freedom
may make them better at the ends of the CDR loops and their stabilizing effects
may improve kinetics. Group II includes the polar residue histidine which is a
stabilizing residue, along with the aromatic residues which have a delocalized π
electron cloud and can participate in electrostatic, van der Waals and hydrogen
bonding. Group II are also stabilizing residues which are often buried in the
CDR’s and are favored for their interaction potential with the antigen with a
relative small entropy loss. They would likely provide improvements in kinetics,
particularly with regard to Koff . Group III includes the aliphatics glycine and
alanine which are small and mobile, favored at the ends of the CDR loop for mo-
bility and possibly faster binding kinetics, but are not at the center of the loop
due to poor interaction potential. Group IV includes polar and charged residues
that have good interaction potential. Asparagine, which is frequently buried in
the CDR and can stabilize through hydrogen bonding to main chain atoms, also
allows increased exposure of aromatic side chains. These residues maintain some
mobility and could be accommodated in most portions of the loop, particularly
regions 2 and 3. Group V includes large, basic residues that have good inter-
action potential, but poor mobility favors their placement in regions 2 and 3.
Proline is included here as an aliphatic residue that tolerates H2O exposure and
is often found at turns [4, 5, 21, 8].
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3.1 Shape Space
As mentioned earlier, our intent is to model the thermodynamic relaxation of
the antibody (Ab)/ antigen (Ag) binding interface. We achieve this goal by
constructing a Markov Chain on the joint shape space of the CDRs and the
Ag epitope(s). Specifically, we restrict our ‘shape’ model to the first two torsion
angles (ϕ and ψ) for each residue.
Let s ∈ S = {0,1,2,3}3N denote the nucleotide sequence encoding for the
CDRs participating in the antigen interaction and the presented antigenic epi-
tope, where N denotes the number of triplets encoding the corresponding amino
acid sequences (note that all introns have been ‘spliced out’ and the genetic
sequences are thought of as contiguous). Translation between the four letter nu-
cleotide sequence to the twenty letter amino acid sequence is achieved through
the DNA genetic code: G : S → {1, 2, . . . , 20}N , for any chain with N amino
acids.
Each of the N residues in the combined Ab/Ag primary sequence s gives rise
to a (two-dimensional) Ramachandran plot for its two primary torsion angles
(ϕi, ψi) for i = 1, 2, . . . , N . Thus, the shape of the entire combined primary
sequence is represented as a point ω = (ϕ1, ψ1, ϕ2, ψ2, . . . , ϕN , ψN ) in a subset
Ω of the N -dimensional topological torus T n, which we refer to as ‘shape space’.
A location map ℓ : G(S)→ {1, 2, 3}N is defined to capture the ‘topography’
of the loops that comprise the CDRs and the antigenic epitope as described in
the previous section. In particular, ℓ (G(s))j = 1 means that the corresponding
residue is in the area immediately attached to the conserved framework. Corre-
spondingly, the value 3 for the location map denotes the top of the exposed loops,
while the value 2 is reserved for residues that transition between the framework
and the bend at the top of the loop.
3.2 Free Energy
We model the free energy of the Ab/Ag complex as a real-valued function
on shape space, G : Ω → R+. We construct this function locally, beginning
with neighborhoods around M Gaussian ‘shape attractors’ [1, 3], ϑj ∈ Ω (j =
1, 2, . . . ,M). In particular, let
G (ω;ϑj) = −Gj(2π)
−N/2 det(Hj)
−1/2 exp
{
−
1
2
(ω − ϑj)
T
H−1j (ω − ϑj)
}
, (1)
denote the potential around attractor ϑj , where Hj is the covariance matrix
corresponding to attractor j. In this paper we consider the special caseHj = ηIN
for all j = 1, 2, . . . ,M . Combining these local ‘attraction zones’, we define the
free energy globally as
G(ω) = min
1≤j≤M
G (ω;ϑj) . (2)
The attractor locations were based on crystallographic studies of immunoglob-
ulins [4, 5]. Figure 1 shows an example of the locations of 91 attractors for Ser-
ine (the ellipses capture the 1σ onfidence levels around the estimated locations,
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Fig. 1. Ramachandran plot for Serine data in CDRs
where available). The attractor strengths were assigned randomly within ranges
that depend on the amino acid group (1-5) and its location code (1, 2 or 3) as
shown in Table 1.
Group Number Location
1 2 3
I
[
10−6, 10−5
] [
10−8, 10−7
] [
10−9, 10−8
]
II
[
10−9, 10−8
] [
10−6, 10−5
] [
10−6, 10−5
]
III
[
10−7, 10−6
] [
10−10, 10−9
] [
10−10, 10−9
]
IV
[
10−8, 10−7
] [
10−7, 10−6
] [
10−7, 10−6
]
V
[
10−10, 10−9
] [
10−9, 10−8
] [
10−8, 10−7
]
Table 1. Ranges of attractor strengths Gj by amino acid group and location code
3.3 Microcanonical Ensemble
The evolution of the joint shape of the Ab/Ag complex is seen as a divergence-
form diffusion (see [22] and the discussion of the Smoluckowski equation in [3]
and references therein) with generator
[Lβf ] = e
βG∇ ·
(
e−βG∇f
)
, (3)
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for any real-valued function f : Ω → R on shape space. The self-adjoint
extension of Lβ generates a Markov process in L
2 (Ω,µβ), where µβ(dx) =
Z−1β e
−βG(ω)µ0(dω) is the Gibbs state at inverse temperature β, with µ0 the
Haar measure on TN [29]. In particular, the process converges to an equilib-
rium state which spends time in the neighborhood of each attractor in inverse
proportion to the free energy barriers that separate the attractors from one an-
other. In the next section we compute those barriers and use them to define
the thermodynamic constants that control the relaxation of the Ab/Ag binding
pocket.
3.4 Barriers and Thermodynamic Constants
We use the free energy function defined in (2) to compute the ‘barrier form’, a
map B : Ω×Ω → Ω with the property that B (ϑi, ϑj) is the conformation ω such
that G (ω;ϑi) = G (ω;ϑj). After some algebra, using the diagonal form of the
covariance matrix described above, we arrive at the following characterization
of B:
B (ϑi, ϑj) = ϑj + λij (ϑi − ϑj) , (4)
where
λij =
(
ϑTj ϑj − ϑ
T
i ϑi
)
− 2η log GiGj
2 (ϑj − ϑi)
T
(ϑj − ϑi)
. (5)
Thus, the free energy level at the barrier is given by
G (B (ϑi, ϑj) ;ϑi) = −(2πη)
−N/2Gj exp

−
(
ϑTj ϑj − ϑ
T
i ϑi − 2η log
Gi
Gj
)2
8η (ϑj − ϑi)
T
(ϑj − ϑi)

 .
(6)
Using the procedure described in [22] and the computation shown in (6), we
define for each attractor i,
Koff(i) = exp
{
−min
j 6=i
G (B (ϑi, ϑj) ;ϑi)
}
(7)
Kon(i) = exp
{
−max
j 6=i
min
k 6=j
G (B (ϑj , ϑk) ;ϑj)
}
(8)
Pi =
Kon(i)
Kon(i) +Koff(i)
(9)
E =
M∑
j=1
P (j) logP (j). (10)
If attractor b corresponds to the bound Ab/Ag state, then the association con-
stant for their interaction is given by Kon(b) (8) and the dissociation constant is
given by Koff(b) (7). Similarly the immunologic affinity is measured by Pb, and
E described the entropy of the particular configuration of attractors.
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3.5 Coalescing Random Walk
Mutations occur with equal frequency at any location in the primary sequence
s. If the resulting triplet codes for a new amino acid (the mutation is not silent),
then the shape attractors change location and strength. Thus, the evolution of
the system over a series of mutations can be thought of as a random walk in ΩN .
If, after a step in this random walk, two attractors satisfy the following equation
G (ϑi;ϑj) ≤ −(2πη)
−N/2Gi ⇐⇒ (ϑi − ϑj)
T
(ϑi − ϑj) ≤ 2η log
Gj
Gi
, (11)
then attractor i merges with attractor j. In fact, often mutations leading to these
‘coalescing’ events reduce the entropy of the system and also help improve the
binding affinity.
4 Results
We amended the random walk described in the previous section by requiring that
a mutation step be accepted only if it does not decrease the affinity, except when,
with probability 1−p, a ‘global jump’ is performed, whose result is accepted (as a
new starting point) irrespective of its effect on affinity ([28]). We have simulated
this ‘restarting’ coalescing random walk for different values of η,M and p. When
low values of p were used (e.g. p = 0.5) the thermodynamic constants and affinity
landscape were explored in breadth. Instead, when we used high values of p (e.g.
p ≥ 0.99) we were able to obtain an in-depth exploration of few affinity hills.
Figure 2 shows the 35 accepted steps of the coalescing random walk in a
simulation run of 5, 000 steps with p = 0.999, η = 9 and M = 50 (only
three global jumps were observed). The simulation was based on the sequence
QGTHVPYTARRSWYFDVWG with
ℓ (G(s)) = (1, 2, 2, 3, 3, 2, 2, 1, 1, 2, 2, 2, 3, 3, 3, 2, 2, 2, 1).
4.1 Affinity Landscape
As a result of our simulation of the coalescing random walk in shape space, we
can estimate the resulting affinity landscape. In all cases, we found the affinity
landscape to be well modeled (R2 > 0.9) by a Gaussian. Figure 3 shows the
normal probability plot for a simulation run with p=0.5, η = 8 andM = 50 using
the sequence and location map described above (µ = 0.4716 and σ = 0.0137).
4.2 Kinetic Evolution
Figure 4 shows the typical evolution of the kinetic components of affinity, for a
simulation with the same example sequence as above, and p = 0.5, η = 8 and
M = 50. For low values of affinity, increases in the association constant Kon play
the biggest role in maturation. Quickly however Kon saturates, and any further
increases in affinity are driven almost entirely by decreases in the dissociation
constant koff . In particular, we can be more than 90% certain that the correlation
between Koff and Pb, ρ (Koff , Pb) ∈ (−0.9,−0.86) while ρ (Kon, Pb) ∈ (0.5, 0.55).
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Fig. 2. Example of affinity maturation and its kinetic components
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Fig. 3. Normal probability plot of affinity from 3, 534 steps of a simulated random walk
in shape space
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Fig. 4. An example of the contributions of Kon and Koff to affinity maturation. All
time series are sorted in order of increasing affinity. Affinity was scaled up by 87% for
visual clarity
4.3 Entropic Maturation Regimes
As discussed earlier, the high specificity of the mature antibody is assumed
to reflect improved a priori shape complementarity with the antigen, therefore
diminishing the entropy change upon binding.
In an effort to elucidate the entropics of maturation, Figure 5 examines the
tail of the percentage drop in entropy during an affinity maturation simulation
following the restarting coalescing random walk with the same parameters as in
the previous section. We see that the entropy drop follows roughly an exponential
distribution, with rate around 1.23.
5 Next Steps
The modeling paradigm described here, although not capturing details of the
mutational effects on the protein dynamics, permits the computation of the
distributions of the thermodynamic constants as well the delineation of the con-
tributions of the kinetic components of affinity. The system also allows analysis
of the entropic trade-off that occurs during the conformational evolution of the
interface.
A further refinement of the model would include the addition of more at-
tractors (perhaps exponentially many in the number of residues) as this would
be a more realistic representation from a protein dynamics perspective. This
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Fig. 5. The distribution of entropy based on 3, 534 steps of a simulated random walk
in shape space
version of the model represents a special case where a single η is used for all of
the attractors; a further improvement would allow η to vary between attractors
and to allow the full covariance matrix H to incorporate off-diagonal elements
capturing more complex attractor geometries.
An important addition would be to explore better the entropics of the affinity
maturation process and the efficiency of the trade-off between decreasing entropy,
affinity and shape complementarity for the antigen. Decreasing entropy may not
be an absolute requirement for affinity maturation and it may represent a more
finely tunable parameter in the maturation process (preliminary unpublished
results not shown here) [30, 31].
References
1. Figge, M.T.: Statistical model for receptor-ligand binding thermodynamics. Phys.
Rev. E 66, 061901 (2002).
2. Kosiol, C., Goldman, N., Buttimore, N.H.: A new criterion and method for amino
acid classification. J. Theor. Biol. 228 (2002) 97–106.
3. Church, B.W., Oresic, M., Shalloway, D.: Tracking metastable states to free-energy
global minima. In: Pardalos, P.M., Shalloway, D., Xue, G (eds.): Global minimiza-
tion of nonconvex energy functions: molecular conformation and protein folding.
DIMACS Series, Vol. 23. American Mathematical Society (1996) 41-64.
4. Al-Lazikni, B., Lesk, A., Chothia, C.: Standard Conformations for the canonical
structures of immunoglobulins. J. Mol. Biol. 273 (1997) 927-948.
Ab/Ag conformations 11
5. Morea, V., Tramontano, A., Rustici, M., Chothia, C., Lesk, A.: Conformations of
the third hypervariable region in the VH domain of immunoglobulins. J. Mol. Biol.
275 (1998) 269-294.
6. Li, Z., Woo, C., Iglesias-Ussel, M., Ronai, D., Scharf, M.: The generation of antibody
diversity through somatic hypermutation and class switch recombination. Genes and
Development 18 (2004) 1-11.
7. Furakawa, K., Shirai, H., Azuma, T., Nakamura, H.: A role of the third
complementarity-determining region in the affinity maturation of an antibody. J.
Biol. Chem. 276 (2001) 27622-27628.
8. Kim, S., Shirai, H., Nakajima, N., Higo, J., Nakamura, H.: Enhanced conformational
diversity search of CDR-H3 in antibodies: role of the first CDR-H3 residue. Proteins
37 (1999) 683-696.
9. Nayak, B., Tuteja, R., Manivel, V., Roy, R., Vishwakarma, R., Rao, K.: B cell
responses to peptide epitope. V. Kinetic regulation of repertoire discrimination and
antibody optimization for epitope. J. Immunol. 161 (1998) 3510-3519.
10. Manivel, V., Sahoo, N., Salunke, D., Rao, K.: Maturation of an antibody response
is governed by modulations in flexibility of the antigen-combining site. Immunity
13 (2000) 611-620.
11. Yiang, J., Swaminathan, C., Huang, Y., Guan, R., Cho, S., Kieke, M., Kranz, D.,
Mariuzza, R., Sundberg, E.: Dissecting cooperative and additive binding energetics
in the affinity maturation pathway of a protein-protein interface. J. Biol. Chem.
278 (2003) 50412-50421.
12. Sagawa, T., Oda, M., Ishimura, M., Furakawa, K., Azuma, T.: Thermodynamic
and kinetic aspects of antibody evolution during immune response to hapten. Mol.
Immunol. 39 (2003) 801-808.
13. Yin, J., Beuscher, A., Andryski, S., Stevens, R., Schultz, P.: Structural plasticity
and the evolution of antibody affinity and specificity. J. Mol. Biol. 330 (2003) 651-
656.
14. Manivel, V., Bayiroglu, F., Siddiqui, Z., Salunke, D., Rao, K.: The primary anti-
body repertoire represents a linked network of degenerate antigen specificities. J.
Immunol. 169 (2002) 888-897.
15. Batista, F., Neuberger, M.: Affinity dependence of the B cell response to antigen:
a threshold, a ceiling and the importance of off-rate. Immunity 8 (1998) 751-759.
16. Dorner, T., Brezinschek, H., Brezinschek, R., Foster, S., Domiati-Saad, R., Lipsky,
P.: Analysis of the frequency and pattern of somatic mutations within nonpro-
ductively rearranged human variable heavy chain genes. J. Immunol. 158 (1997)
2779-2789.
17. Covell, D., Wallqvist, D.: Analysis of protein-protein interactions and the effects
of amino acid mutations on their energetics. J. Mol Biol (1997), 281–297.
18. Dorner, T.: Analysis of the targeting of the hypermutational machinery and the
impact of subsequent selection. Immunol. Rev. 162 (1998), 161-171.
19. Foote, J., Milstein, C.: Kinetic maturation of an immune response. Nature 352
(1991), 530-532.
20. Goyenechea, B., Milstein, C.: Modifying the sequence of an immunoglobulin v gene
alters the resulting pattern of hypermutation. Immunology 93 (1996), 13979-13984.
21. Padlan, E.: Anatomy of the antibody molecule. Mol. Immunol. 31 (1994) 169-217.
22. Holley, R., Kusuoka, S., Stroock, D.: Asymptotics of the spectral gap with ap-
plications to the theory of simulated annealing. J. Functional Analysis 83 (1989)
333-347.
23. Wedemayer, G., Patten, P., Wang, L., Schultz, P., Stevens, R.: Structural insights
into the evolution of an antibody combining site. Science 276 (1997) 1421-1423.
12 Patricia Theodosopoulos et al.
24. Guermonprez, P. England, P., Bedouelle, H., Leclerc, C.: The rate of dissocia-
tion between antibody and antigen determines the efficiency of antibody-mediated
antigen presentation to T cells. J. Immunol. 161 (1998) 4542-4548.
25. Furakawa, K., Akasako-Furakawa, A., Shirai, H., Nakamura, H., Azuma, T.: Junc-
tional amino acids determine the maturation pathway of an antibody. Immunity 11
(1999) 329-338.
26. Krogsgaard, M., Prado, N., Adams, E., He, X., Chow, D., Wilson, D., Garcia, K.,
Davis, M.: Evidence that structural rearrangements and/or flexibility during TCR
binding can contribute to T cell activation. Mol. Cell 12 (2003) 1367-1368.
27. Branden, C., Tooze, J.: Introduction to Protein Structure. Garland Pub. (1991).
28. Theodosopoulos, P., Theodosopoulos, T.: Evolution at the edge of chaos: a
paradigm for the maturation of the humoral immune response. In: L.F.Landweber
and E.Winfree (eds.): Evolution as Computation. Natural Computing Series,
Springer (2002) 41-66.
29. Stroock, D.W., Zeitouni, O.: Microcanonical distributions, Gibbs states and the
equivalence of ensembles. In: Random walks, Brownian motion and interacting par-
ticle systems. Progr. Probab., Birkha¨user Boston, (1991) 399-424.
30. Kwong, P., Doyle, M., Casper, D., Cicala, C., Leavitt, S., Majeed, S., Steenbeke,
T., Venturi, M., Chaiken, I., Fung, M., Katinger, H., Parren, P., Robinson, J., Van
Ryk, D., Wang, L., Burton, D., Freire, E., Wyatt, R., Sodroski, J., Hendrickson, W.,
Arthos, J.: HIV-1 evades antibody-mediated neutralization through conformational
masking of receptor-binding sites. Nature 420 (2002) 678-682.
31. Zwick, M., Parren, P., Saphire, E., Church, S., Wang, M., Scott, J., Dawson, P.,
Wilson, I., Burton, D.: Molecular features of the broadly neutralizing immunoglobu-
lin G1 b12 required for recognition of human immunodeficiency virus type 1 gp120.
J. Virol. 77 (2003) 5863-5876.
